Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Zfp874 Inhibitors

Zfp874 inhibitors represent a class of small molecules or compounds designed to selectively interfere with the activity of the Zfp874 protein, a zinc finger protein involved in transcriptional regulation. Zinc finger proteins like Zfp874 are part of a large family of DNA-binding proteins that utilize zinc ions to stabilize their structures, typically interacting with DNA through specific motifs that regulate gene expression. By inhibiting the activity of Zfp874, these compounds may disrupt the binding of this protein to its target sequences on DNA, thereby altering the transcriptional processes it modulates. Such inhibition can lead to downstream effects on the expression of genes under Zfp874's control, which could span various biological pathways, from cell cycle regulation to epigenetic modifications. Inhibitors within this class are often characterized by their ability to bind directly to the protein's DNA-binding domain or indirectly influence its regulatory function, preventing it from engaging with its molecular targets.

The development of Zfp874 inhibitors is grounded in a deep understanding of the protein's structure-function relationship. The zinc finger domains, which coordinate zinc ions to maintain the protein's conformation, are highly conserved and serve as critical binding sites. Researchers often explore these domains for inhibitor design, aiming to exploit small pockets or grooves that can be targeted by small molecules. These inhibitors may function through several mechanisms, including competitive inhibition with the protein's natural DNA substrate or by inducing conformational changes that render the protein inactive. In addition to their structural specificity, the biophysical properties of these inhibitors, such as their binding affinity and selectivity for Zfp874 over other zinc finger proteins, are crucial to their activity. Their development requires advanced techniques such as molecular modeling, high-throughput screening, and protein-ligand interaction assays, which facilitate the identification and optimization of candidate molecules.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

ATRA, a derivative of vitamin A, influences the RAR/RXR signaling pathway, leading to altered expression of Zfp874a. ATRA binds to retinoic acid receptors, modulating downstream transcription factors that indirectly impact the gene.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

SAHA inhibits histone deacetylases, affecting chromatin structure and accessibility. This epigenetic modification indirectly hinders Zfp874a transcription by modifying the chromatin environment at its regulatory regions.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, disrupts the PI3K/Akt pathway. Zfp874a is downstream of Akt, and inhibition of this pathway by LY294002 indirectly leads to decreased Zfp874a activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits MEK1, preventing activation of the MAPK pathway. Zfp874a expression is influenced by MAPK signaling, making PD98059 an indirect inhibitor by disrupting this pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAPK, impacting downstream targets. Zfp874a expression is modulated by p38 MAPK, making SB203580 an indirect inhibitor by disrupting this signaling cascade.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK, a kinase involved in stress response pathways. Zfp874a expression is influenced by JNK signaling, making SP600125 an indirect inhibitor by disrupting this stress-responsive pathway.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

17-AAG inhibits Hsp90, affecting the stability of client proteins, including those in the Zfp874a regulatory network. This leads to altered protein folding and degradation, indirectly influencing Zfp874a expression.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

BAY 11-7082 inhibits NF-κB activation, a transcription factor involved in Zfp874a regulation. Inhibition of NF-κB by BAY 11-7082 indirectly impacts Zfp874a transcription by altering the availability of transcriptional machinery.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A inhibits histone deacetylases, altering chromatin accessibility. This epigenetic modification indirectly hinders Zfp874a transcription by modifying the chromatin environment at its regulatory regions.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits PI3K, disrupting the PI3K/Akt pathway. Zfp874a is downstream of Akt, and inhibition of this pathway by Wortmannin indirectly leads to decreased Zfp874a activity.